Share Price and Basic Stock Data
Last Updated: October 18, 2025, 6:56 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Tijaria Polypipes Ltd operates in the plastics industry, focusing on pipes and fittings. The company’s recent revenue trajectory has been concerning, with reported sales plunging from ₹149.53 Cr in FY 2019 to just ₹13.85 Cr in FY 2023. This decline reflects a significant downturn in operational performance, with sales further dwindling to ₹0.15 Cr in FY 2024 and dropping to ₹0.00 Cr in FY 2025. The quarterly sales figures reveal a troubling trend, with the most recent quarter (Sep 2023) recording no sales at all. This stark reduction in revenue points to serious operational challenges, potentially stemming from market dynamics or internal inefficiencies. The company’s ability to generate income has been severely hampered, as evidenced by the consecutive negative operating profits and net profits, underscoring a critical need for strategic reassessment to recover market position and restore revenue growth.
Profitability and Efficiency Metrics
Profitability metrics for Tijaria Polypipes Ltd paint a bleak picture. The company reported a net profit of -₹5.43 Cr for FY 2025, continuing a trend of losses that has persisted for several years. Operating profit margins (OPM) have been negative, reaching -30.69% in FY 2023, with further declines noted in subsequent reporting periods. Efficiency ratios reveal a concerning cash conversion cycle, which stood at an alarming 503.84 days in FY 2023, indicating significant delays in converting investments into cash flow. The interest coverage ratio (ICR) is marginal at 1.12x, raising concerns about the firm’s ability to meet its interest obligations. Return on capital employed (ROCE) is also negative at -5.05% for FY 2025, suggesting that the capital invested in the business is not yielding returns. The company must address these profitability and efficiency issues to improve its financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Tijaria Polypipes Ltd reveals a precarious financial position, characterized by a negative reserve of ₹61.13 Cr and borrowings amounting to ₹77.40 Cr. The debt-to-equity ratio stands at -2.38, indicating that the company’s liabilities significantly exceed its equity, which poses a considerable risk to financial stability. Additionally, the book value per share is reported at -₹11.35, further underscoring the company’s negative net worth. Liquidity ratios, however, present a slightly more favorable picture, with a current ratio of 2.53 and a quick ratio of 2.50, suggesting that the company can cover its short-term liabilities. Nevertheless, the overall financial ratios highlight a company in distress, with diminishing asset values and a need for restructuring to restore investor confidence and operational viability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Tijaria Polypipes Ltd indicates a diverse ownership structure, with promoters holding 35.27% of the shares, while the public accounts for a substantial 60.13%. Foreign institutional investors (FIIs) represent a modest 4.61%, suggesting limited international confidence in the company. Domestic institutional investors (DIIs) have no stake, reflecting a cautious sentiment among institutional stakeholders. The total number of shareholders has increased to 11,546, which may indicate a growing interest at the retail level despite the company’s poor financial performance. The relatively high public shareholding could offer some stability, yet the lack of institutional backing raises concerns about the company’s future prospects. Investor confidence is likely to remain fragile until there are clear signs of operational recovery and improved financial metrics.
Outlook, Risks, and Final Insight
If Tijaria Polypipes Ltd can stabilize its operations and improve revenue generation, there may be potential for recovery. However, significant risks remain, including high debt levels, ongoing operational losses, and a lack of institutional support. The company faces the challenge of addressing its operational inefficiencies, which have led to a protracted decline in sales and profitability. Additionally, market conditions in the plastics sector could further impact its recovery efforts. If margins can be improved and effective cost management strategies are implemented, there is a possibility of regaining market confidence and stabilizing financial performance. However, without decisive action to rectify its current trajectory, the company may continue to struggle in an increasingly competitive market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Tijaria Polypipes Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dutron Polymers Ltd | 69.8 Cr. | 116 | 207/110 | 33.6 | 48.6 | 1.29 % | 12.3 % | 9.68 % | 10.0 |
| Captain Polyplast Ltd | 456 Cr. | 76.2 | 128/58.4 | 24.5 | 25.5 | 0.00 % | 16.1 % | 15.0 % | 2.00 |
| Captain Pipes Ltd | 202 Cr. | 13.1 | 21.0/11.7 | 54.5 | 2.58 | 0.00 % | 17.0 % | 13.5 % | 1.00 |
| Caprihans India Ltd | 186 Cr. | 127 | 184/114 | 196 | 0.00 % | 0.78 % | 18.9 % | 10.0 | |
| Ashish Polyplast Ltd | 13.0 Cr. | 38.3 | 63.9/30.0 | 43.4 | 19.8 | 0.00 % | 5.09 % | 2.58 % | 10.0 |
| Industry Average | 5,696.13 Cr | 217.83 | 51.50 | 79.71 | 0.21% | 10.40% | 10.62% | 8.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.91 | 0.09 | 0.00 | 3.84 | 0.04 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 11.53 | 0.43 | 0.29 | 5.86 | 0.23 | 0.01 | 0.03 | 0.20 | 0.17 | 0.04 | 0.04 | 0.05 | 0.10 |
| Operating Profit | -1.62 | -0.34 | -0.29 | -2.02 | -0.19 | -0.01 | -0.03 | -0.09 | -0.17 | -0.04 | -0.04 | -0.05 | -0.10 |
| OPM % | -16.35% | -377.78% | -52.60% | -475.00% | -81.82% | ||||||||
| Other Income | 0.06 | 0.03 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.08 | 0.13 | 0.05 | 0.06 | -3.06 | 0.02 |
| Interest | 1.96 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.85 | 0.83 | 0.83 | 0.80 | 0.68 | 0.69 | 0.69 | 0.70 | 0.58 | 0.94 | 0.76 | 0.03 | 0.19 |
| Profit before tax | -4.37 | -1.17 | -1.10 | -2.79 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -4.37 | -1.17 | -1.11 | -2.80 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 |
| EPS in Rs | -1.53 | -0.41 | -0.39 | -0.98 | -0.30 | -0.23 | -0.24 | -0.25 | -0.22 | -0.32 | -0.26 | -1.10 | -0.09 |
Last Updated: August 20, 2025, 2:15 am
Below is a detailed analysis of the quarterly data for Tijaria Polypipes Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Mar 2025) to 0.10 Cr., marking an increase of 0.05 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.10 Cr.. The value appears to be declining and may need further review. It has decreased from -0.05 Cr. (Mar 2025) to -0.10 Cr., marking a decrease of 0.05 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from -3.06 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 3.08 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -3.14 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 2.87 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -3.14 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 2.87 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.09. The value appears strong and on an upward trend. It has increased from -1.10 (Mar 2025) to -0.09, marking an increase of 1.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108.57 | 69.11 | 87.03 | 63.54 | 76.34 | 149.53 | 73.39 | 62.46 | 54.88 | 13.85 | 0.15 | -0.00 | 0.00 |
| Expenses | 99.49 | 61.05 | 80.92 | 66.07 | 83.95 | 129.73 | 64.62 | 66.11 | 63.93 | 18.10 | 0.45 | 0.27 | 0.23 |
| Operating Profit | 9.08 | 8.06 | 6.11 | -2.53 | -7.61 | 19.80 | 8.77 | -3.65 | -9.05 | -4.25 | -0.30 | -0.27 | -0.23 |
| OPM % | 8.36% | 11.66% | 7.02% | -3.98% | -9.97% | 13.24% | 11.95% | -5.84% | -16.49% | -30.69% | -200.00% | ||
| Other Income | -0.00 | 5.05 | 0.19 | -1.42 | -1.06 | 0.67 | 0.36 | 0.91 | -0.11 | 0.13 | 0.17 | -2.83 | -2.93 |
| Interest | 8.85 | 8.73 | 9.10 | 7.18 | 7.51 | 7.94 | 6.40 | 6.51 | 8.42 | 2.01 | 0.02 | 0.02 | 0.00 |
| Depreciation | 10.43 | 13.53 | 11.80 | 9.78 | 8.23 | 6.34 | 5.20 | 4.76 | 4.13 | 3.32 | 2.76 | 2.31 | 1.92 |
| Profit before tax | -10.20 | -9.15 | -14.60 | -20.91 | -24.41 | 6.19 | -2.47 | -14.01 | -21.71 | -9.45 | -2.91 | -5.43 | -5.08 |
| Tax % | 5.98% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | |
| Net Profit | -10.80 | -9.15 | -14.60 | -20.92 | -24.41 | 6.19 | -2.46 | -14.01 | -21.70 | -9.46 | -2.92 | -5.43 | -5.08 |
| EPS in Rs | -4.57 | -3.87 | -6.18 | -8.85 | -10.33 | 2.32 | -0.86 | -4.89 | -7.58 | -3.30 | -1.02 | -1.90 | -1.77 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 15.28% | -59.56% | -43.29% | -16.68% | 125.36% | -139.74% | -469.51% | -54.89% | 56.41% | 69.13% | -85.96% |
| Change in YoY Net Profit Growth (%) | 0.00% | -74.84% | 16.28% | 26.61% | 142.04% | -265.10% | -329.77% | 414.62% | 111.29% | 12.73% | -155.09% |
Tijaria Polypipes Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 14% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: June 16, 2025, 11:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 | 26.72 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 |
| Reserves | 55.50 | 46.31 | 31.71 | 10.79 | -11.84 | -5.37 | -7.73 | -21.66 | -43.35 | -52.78 | -55.70 | -61.13 |
| Borrowings | 65.58 | 62.07 | 64.63 | 67.23 | 69.90 | 54.12 | 50.76 | 65.88 | 69.15 | 76.36 | 72.41 | 77.40 |
| Other Liabilities | 10.00 | 13.54 | 10.87 | 13.36 | 30.23 | 35.10 | 24.14 | 24.02 | 13.27 | 9.32 | 9.18 | 9.58 |
| Total Liabilities | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 |
| Fixed Assets | 90.33 | 75.67 | 65.41 | 57.71 | 47.13 | 39.19 | 34.52 | 33.56 | 28.79 | 25.31 | 22.55 | 17.12 |
| CWIP | 7.03 | 1.25 | 1.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 57.35 | 68.63 | 64.07 | 57.30 | 64.79 | 71.38 | 61.28 | 63.18 | 38.91 | 36.22 | 31.97 | 37.36 |
| Total Assets | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 |
Below is a detailed analysis of the balance sheet data for Tijaria Polypipes Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 28.63 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 28.63 Cr..
- For Reserves, as of Mar 2025, the value is -61.13 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -55.70 Cr. (Mar 2024) to -61.13 Cr., marking a decline of 5.43 Cr..
- For Borrowings, as of Mar 2025, the value is 77.40 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 72.41 Cr. (Mar 2024) to 77.40 Cr., marking an increase of 4.99 Cr..
- For Other Liabilities, as of Mar 2025, the value is 9.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.18 Cr. (Mar 2024) to 9.58 Cr., marking an increase of 0.40 Cr..
- For Total Liabilities, as of Mar 2025, the value is 54.48 Cr.. The value appears to be improving (decreasing). It has decreased from 54.52 Cr. (Mar 2024) to 54.48 Cr., marking a decrease of 0.04 Cr..
- For Fixed Assets, as of Mar 2025, the value is 17.12 Cr.. The value appears to be declining and may need further review. It has decreased from 22.55 Cr. (Mar 2024) to 17.12 Cr., marking a decrease of 5.43 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 37.36 Cr.. The value appears strong and on an upward trend. It has increased from 31.97 Cr. (Mar 2024) to 37.36 Cr., marking an increase of 5.39 Cr..
- For Total Assets, as of Mar 2025, the value is 54.48 Cr.. The value appears to be declining and may need further review. It has decreased from 54.52 Cr. (Mar 2024) to 54.48 Cr., marking a decrease of 0.04 Cr..
However, the Borrowings (77.40 Cr.) are higher than the Reserves (-61.13 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -56.50 | -54.01 | -58.52 | -69.76 | -77.51 | -34.32 | -41.99 | -69.53 | -78.20 | -80.61 | -72.71 | -77.67 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.70 | 167.26 | 103.97 | 152.86 | 163.47 | 136.04 | 198.19 | 218.50 | 167.67 | 659.90 | 60,784.67 | |
| Inventory Days | 71.18 | 190.53 | 168.43 | 147.34 | 85.65 | 29.43 | 100.16 | 109.28 | 39.39 | 11.91 | 997.67 | |
| Days Payable | 31.01 | 85.09 | 46.37 | 71.98 | 161.85 | 116.40 | 175.15 | 114.50 | 72.58 | 167.97 | 16,863.00 | |
| Cash Conversion Cycle | 133.86 | 272.71 | 226.03 | 228.22 | 87.27 | 49.07 | 123.19 | 213.27 | 134.49 | 503.84 | 44,919.33 | |
| Working Capital Days | 13.72 | 67.66 | 15.81 | 57.79 | -31.08 | 34.20 | 80.12 | 153.69 | 67.91 | 324.15 | 30,343.67 | |
| ROCE % | -0.90% | -3.35% | -4.29% | -10.73% | -16.85% | 18.22% | 5.36% | -10.44% | -20.41% | -13.88% | -5.88% | -5.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Diluted EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Cash EPS (Rs.) | -1.09 | -0.05 | -2.60 | -6.14 | -3.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.05 | 4.84 | 19.17 | 21.82 |
| PBDIT / Share (Rs.) | 0.01 | -0.04 | -1.44 | -3.20 | -1.56 |
| PBIT / Share (Rs.) | -0.79 | -1.01 | -2.14 | -4.64 | -3.23 |
| PBT / Share (Rs.) | -0.80 | -1.02 | -3.30 | -7.58 | -4.89 |
| Net Profit / Share (Rs.) | -1.90 | -1.02 | -3.30 | -7.58 | -4.89 |
| PBDIT Margin (%) | 0.00 | -79.03 | -29.67 | -16.67 | -7.16 |
| PBIT Margin (%) | 0.00 | -1940.33 | -44.21 | -24.20 | -14.79 |
| PBT Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Net Profit Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -201.27 |
| Return on Capital Employeed (%) | -6.91 | -7.50 | -14.82 | -30.52 | -13.83 |
| Return On Assets (%) | -9.96 | -5.34 | -15.36 | -32.05 | -14.46 |
| Long Term Debt / Equity (X) | -2.02 | -2.42 | -2.71 | -3.96 | 8.60 |
| Total Debt / Equity (X) | -2.38 | -2.67 | -3.16 | -4.70 | 9.46 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.21 | 0.66 | 0.64 |
| Current Ratio (X) | 1.66 | 1.88 | 1.71 | 1.54 | 2.04 |
| Quick Ratio (X) | 1.64 | 1.86 | 1.69 | 1.30 | 1.55 |
| Inventory Turnover Ratio (X) | 0.00 | 0.10 | 3.43 | 4.94 | 3.54 |
| Interest Coverage Ratio (X) | 1.12 | -6.99 | -1.24 | -1.09 | -0.93 |
| Interest Coverage Ratio (Post Tax) (X) | -128.14 | -171.73 | -1.84 | -1.58 | -1.94 |
| Enterprise Value (Cr.) | 91.12 | 107.14 | 84.52 | 84.89 | 78.81 |
| EV / Net Operating Revenue (X) | 0.00 | 721.44 | 6.10 | 1.55 | 1.26 |
| EV / EBITDA (X) | 4578.83 | -912.86 | -20.57 | -9.27 | -17.60 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 245.76 | 0.90 | 0.33 | 0.28 |
| Price / BV (X) | -0.47 | -1.35 | -0.52 | -1.25 | 2.59 |
| Price / Net Operating Revenue (X) | 0.00 | 250.00 | 0.90 | 0.33 | 0.28 |
| EarningsYield | -0.34 | -0.07 | -0.75 | -1.18 | -0.77 |
After reviewing the key financial ratios for Tijaria Polypipes Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.09. This value is below the healthy minimum of 3. It has decreased from -0.05 (Mar 24) to -1.09, marking a decrease of 1.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.79. This value is below the healthy minimum of 0. It has increased from -1.01 (Mar 24) to -0.79, marking an increase of 0.22.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.80. This value is below the healthy minimum of 0. It has increased from -1.02 (Mar 24) to -0.80, marking an increase of 0.22.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.90. This value is below the healthy minimum of 2. It has decreased from -1.02 (Mar 24) to -1.90, marking a decrease of 0.88.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -79.03 (Mar 24) to 0.00, marking an increase of 79.03.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,940.33 (Mar 24) to 0.00, marking an increase of 1,940.33.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -6.91. This value is below the healthy minimum of 10. It has increased from -7.50 (Mar 24) to -6.91, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is -9.96. This value is below the healthy minimum of 5. It has decreased from -5.34 (Mar 24) to -9.96, marking a decrease of 4.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 0.2. It has increased from -2.42 (Mar 24) to -2.02, marking an increase of 0.40.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.38. This value is within the healthy range. It has increased from -2.67 (Mar 24) to -2.38, marking an increase of 0.29.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 1.88 (Mar 24) to 1.66, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.64, marking a decrease of 0.22.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 3. It has increased from -6.99 (Mar 24) to 1.12, marking an increase of 8.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -128.14. This value is below the healthy minimum of 3. It has increased from -171.73 (Mar 24) to -128.14, marking an increase of 43.59.
- For Enterprise Value (Cr.), as of Mar 25, the value is 91.12. It has decreased from 107.14 (Mar 24) to 91.12, marking a decrease of 16.02.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 721.44 (Mar 24) to 0.00, marking a decrease of 721.44.
- For EV / EBITDA (X), as of Mar 25, the value is 4,578.83. This value exceeds the healthy maximum of 15. It has increased from -912.86 (Mar 24) to 4,578.83, marking an increase of 5,491.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 245.76 (Mar 24) to 0.00, marking a decrease of 245.76.
- For Price / BV (X), as of Mar 25, the value is -0.47. This value is below the healthy minimum of 1. It has increased from -1.35 (Mar 24) to -0.47, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 250.00 (Mar 24) to 0.00, marking a decrease of 250.00.
- For EarningsYield, as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has decreased from -0.07 (Mar 24) to -0.34, marking a decrease of 0.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tijaria Polypipes Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -6.91% (Industry Average ROCE: 10.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 10.62%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -128.14
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 51.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | SP-1-2316, RIICO Industries Area, Jaipur Rajasthan 302022 | investors@tijaria-pipes.com http://www.tijaria-pipes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Alok Jain Tijaria | Managing Director |
| Mr. Vikas Jain Tijaria | Whole Time Director - Marketing |
| Mr. Praveen Jain Tijaria | Whole Time Director - Production |
| Mr. Vineet Jain Tijaria | Whole Time Director - Finance |
| Ms. Khushi Nagrath | Ind. Non-Executive Woman Director |
| Mr. Ashok Kumar | Ind. Non-Executive Director |
| Mrs. Anjali Udhwani | Ind. Non-Executive Woman Director |
| Mrs. Sonu Surana | Ind. Non-Executive Woman Director |
FAQ
What is the intrinsic value of Tijaria Polypipes Ltd?
Tijaria Polypipes Ltd's intrinsic value (as of 18 October 2025) is 20.93 which is 229.09% higher the current market price of 6.36, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 18.2 Cr. market cap, FY2025-2026 high/low of 14.2/4.88, reserves of ₹-61.13 Cr, and liabilities of 54.48 Cr.
What is the Market Cap of Tijaria Polypipes Ltd?
The Market Cap of Tijaria Polypipes Ltd is 18.2 Cr..
What is the current Stock Price of Tijaria Polypipes Ltd as on 18 October 2025?
The current stock price of Tijaria Polypipes Ltd as on 18 October 2025 is 6.36.
What is the High / Low of Tijaria Polypipes Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tijaria Polypipes Ltd stocks is 14.2/4.88.
What is the Stock P/E of Tijaria Polypipes Ltd?
The Stock P/E of Tijaria Polypipes Ltd is .
What is the Book Value of Tijaria Polypipes Ltd?
The Book Value of Tijaria Polypipes Ltd is 11.4.
What is the Dividend Yield of Tijaria Polypipes Ltd?
The Dividend Yield of Tijaria Polypipes Ltd is 0.00 %.
What is the ROCE of Tijaria Polypipes Ltd?
The ROCE of Tijaria Polypipes Ltd is 5.05 %.
What is the ROE of Tijaria Polypipes Ltd?
The ROE of Tijaria Polypipes Ltd is %.
What is the Face Value of Tijaria Polypipes Ltd?
The Face Value of Tijaria Polypipes Ltd is 10.0.